Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MB-001 by Mage Biologics for Ulcerative Colitis: Likelihood of Approval
MB-001 is under clinical development by Mage Biologics and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase...